Taiping Zhang

9.8k total citations · 2 hit papers
219 papers, 5.6k citations indexed

About

Taiping Zhang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Taiping Zhang has authored 219 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Oncology, 77 papers in Molecular Biology and 72 papers in Cancer Research. Recurrent topics in Taiping Zhang's work include Pancreatic and Hepatic Oncology Research (128 papers), Pancreatitis Pathology and Treatment (42 papers) and Neuroendocrine Tumor Research Advances (40 papers). Taiping Zhang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (128 papers), Pancreatitis Pathology and Treatment (42 papers) and Neuroendocrine Tumor Research Advances (40 papers). Taiping Zhang collaborates with scholars based in China, United States and United Kingdom. Taiping Zhang's co-authors include Yupei Zhao, Lei You, Gang Yang, Lianfang Zheng, Zhe Cao, Li Zhou, Mengyu Feng, Wenhao Luo, Guangbing Xiong and Jiangdong Qiu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Taiping Zhang

211 papers receiving 5.6k citations

Hit Papers

Targeting hypoxic tumor microenvironment in pancreatic ca... 2021 2026 2022 2024 2021 2021 50 100 150 200 250

Peers

Taiping Zhang
Liang Liu China
Ye Xu China
David W. Dawson United States
Peter Olson United States
Jie Hua China
Taiping Zhang
Citations per year, relative to Taiping Zhang Taiping Zhang (= 1×) peers Muh‐Hwa Yang

Countries citing papers authored by Taiping Zhang

Since Specialization
Citations

This map shows the geographic impact of Taiping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taiping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taiping Zhang more than expected).

Fields of papers citing papers by Taiping Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taiping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taiping Zhang. The network helps show where Taiping Zhang may publish in the future.

Co-authorship network of co-authors of Taiping Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Taiping Zhang. A scholar is included among the top collaborators of Taiping Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taiping Zhang. Taiping Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuanyang, Feng Lin, Gang Yang, et al.. (2025). RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. Science Advances. 11(37). eadw9519–eadw9519.
2.
Wu, Jiahui, et al.. (2024). Effect of polyethylene microplastics on soil organic carbon pool dynamics in the soil-rhizosphere-alfalfa system. Journal of environmental chemical engineering. 12(6). 114724–114724. 4 indexed citations
3.
Qiu, Jiangdong, Yifan Fu, Jun Wang, et al.. (2024). Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion. Cancer Letters. 601. 217193–217193. 8 indexed citations
4.
Wang, Ruobing, Guangyu Chen, Yueze Liu, et al.. (2024). FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. Cancer Research. 84(16). 2607–2625. 4 indexed citations
5.
Luo, Wenhao, Hao Chen, Zhe Cao, et al.. (2024). Advances in Screening and Early Diagnosis of Pancreatic Cancer. 3(3). 154–162.
6.
Ren, Bo, et al.. (2024). Microbiota-metabolism-epigenetics-immunity axis in cancer. Frontiers in Immunology. 15. 1449912–1449912. 3 indexed citations
7.
Dai, Menghua, Pengyu Li, Qiang Xu, et al.. (2024). Learning curve of robotic pancreatoduodenectomy by a single surgeon with extensive laparoscopic pancreatoduodenectomy experience. Journal of Robotic Surgery. 18(1). 298–298. 5 indexed citations
8.
Luo, Wenhao & Taiping Zhang. (2023). Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma. Cancer Letters. 567. 216279–216279. 21 indexed citations
9.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis. European Journal of Nuclear Medicine and Molecular Imaging. 50(13). 4036–4050. 16 indexed citations
10.
Ding, Jie, Jiangdong Qiu, Zhixin Hao, et al.. (2023). Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. European Journal of Nuclear Medicine and Molecular Imaging. 50(6). 1780–1791. 26 indexed citations
11.
Chen, Guangyu, Yueze Liu, Dan Su, et al.. (2023). Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Cellular Oncology. 46(6). 1691–1708. 1 indexed citations
12.
Wu, Peng, Zixing Wang, Wei Han, et al.. (2023). Network prediction of surgical complication clusters: a prospective multicenter cohort study. Science China Life Sciences. 66(7). 1636–1646. 1 indexed citations
13.
Yang, Gang, Zhe Cao, Wenbo Guo, et al.. (2021). Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. Clinical Cancer Research. 27(12). 3383–3396. 59 indexed citations
14.
Yang, Gang, Guangbing Xiong, Mengyu Feng, et al.. (2020). OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2. Molecular Cancer Research. 18(5). 685–697. 47 indexed citations
15.
Zhang, Taiping, Quan Liao, Menghua Dai, et al.. (2020). Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation. Protein & Cell. 12(2). 128–144. 56 indexed citations
16.
Wang, Peng‐Hui, et al.. (2016). Comparing the clinical characteristics of IgG4-related sclerosing cholangitis with primary sclerosing cholangitis. Zhonghua gan-dan waike zazhi. 22(5). 315–319.
17.
Liu, Bei, Laura H. Tang, Zhaojun Liu, et al.. (2014). α-Internexin: A Novel Biomarker for Pancreatic Neuroendocrine Tumor Aggressiveness. The Journal of Clinical Endocrinology & Metabolism. 99(5). E786–E795. 26 indexed citations
18.
Zhan, Hanxiang, Jianwei Xu, Dong Wu, Taiping Zhang, & Sanyuan Hu. (2014). Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters. 357(2). 429–437. 66 indexed citations
19.
Zhang, Taiping. (2008). Diagnosis and treatment of 404 cases of insulinoma.
20.
Zhang, Taiping & Shaolin Peng. (2000). Introduution to the Origin and 1volLtion of Pornelo and Its DistribLtion in China. Shengtaixue zazhi. 19(5). 58–61. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026